全部

1·Stent thrombosis was also nearly identical in the two groups.

支架血栓发生率在两组也近于相同。

2·Background - Stent thrombosis is a lethal complication of endovascular intervention.

背景-支架血栓是血管内介入手术的致命的并发症。

3·During the 9 months follow-up period, there were no deaths or cases of stent thrombosis.

在随后的9个月内未发生死亡和支架血栓血栓形成的情况。

4·No stent thrombosis was observed in any of the patients within 2 years of clinical follow-up.

在接下来2年的临床随访中，均无支架内血栓形成。

5·But physicians should be concerned that we've not solved the problem of late stent thrombosis.

但是内科医生应注意，我们还没有解决晚期支架血栓形成问题。

6·No stent thrombosis was observed in the Alpha stent group within 2 years of clinical follow-up.

在接下来2年的临床随访中，阿尔法支架组均没有发现支架内血栓形成。

7·The cost implications are negligible and the benefits on a reduction in stent thrombosis are large.

这对成本的影响可以忽略不计，而在减少支架血栓形成上的获益却是巨大的。

8·Attention has recently been focused on late stent thrombosis related to the use of drug-eluting stents.

但最近药物支架晚期血栓的问题倍受关注。

9·This was associated with worse clinical outcome, in particular, higher rates of TLR and stent thrombosis.

与不良临床结果相关，尤其是较高的TLR(靶病变重建率)和支架血栓的发生率。

10·Objective To investigate individual variations of platelet inhibition after Plavix being administered to prevent clinic events and stent thrombosis.

目的： 研究预防支架术后临床事件和血栓形成服用波力维后，血小板抑制的个体差别。